The glutamate antagonist Riluzole suppresses intracortical facilitation

[1]  Walter Paulus,et al.  The effect of lorazepam on the motor cortical excitability in man , 1996, Experimental Brain Research.

[2]  R. Benecke,et al.  On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects , 2004, Experimental Brain Research.

[3]  Christopher R. Jones,et al.  Changes in excitability of motor cortical circuitry in primary restless legs syndrome , 1999, Neurology.

[4]  A. Doble.  The pharmacology and mechanism of action of riluzole , 1996, Neurology.

[5]  J. Rothwell,et al.  Interaction between intracortical inhibition and facilitation in human motor cortex. , 1996, The Journal of physiology.

[6]  W. Paulus,et al.  M64 Hyperexcitability of motor cortex in amyotrophic lateral sclerosis: Evidence from paired magnetic stimulation , 1996 .

[7]  P. Benfield,et al.  Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. , 1996, Drugs.

[8]  A. Mikulec,et al.  Riluzole Anesthesia: Use-Dependent Block of Presynaptic Glutamate Fibers , 1996, Anesthesiology.

[9]  A. Schulze-Bonhage,et al.  Effects of carbamazepine on cortical excitatory and inhibitory phenomena: a study with paired transcranial magnetic stimulation. , 1996, Electroencephalography and clinical neurophysiology.

[10]  B. Steinhoff,et al.  Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study , 1996, Annals of neurology.

[11]  Ichiro Kanazawa,et al.  Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders , 1996, Journal of the Neurological Sciences.

[12]  P. Leigh,et al.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.

[13]  J. Rothwell,et al.  Changes in the balance between motor cortical excitation and inhibition in focal, task specific dystonia. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[14]  R. Inzelberg,et al.  Changes in excitability of motor cortical circuitry in patients with parkinson's disease , 1995, Annals of neurology.

[15]  C. Taylor,et al.  Emerging perspectives on the mechanism of action of gabapentin , 1994, Neurology.

[16]  I. Kanazawa,et al.  Motor cortex inhibition in patients with ataxia. , 1994, Electroencephalography and clinical neurophysiology.

[17]  C. Taylor,et al.  Emerging perspectives on the mechanism of action of gabapentin , 1994, Neurology.

[18]  J. Mantz,et al.  Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes. , 1994, European journal of pharmacology.

[19]  M. Rogawski.  Riluzole in amyotrophic lateral sclerosis. , 1994, The New England journal of medicine.

[20]  K. Chiappa,et al.  Cortical and spinal motor excitability during the transcranial magnetic stimulation silent period in humans , 1993, Brain Research.

[21]  C. Marsden,et al.  Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.

[22]  M. Fisher.  AAEM minimonograph #13: H reflexes and F waves: Physiology and clinical indications , 1992, Muscle & nerve.

[23]  B. Meldrum,et al.  2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I Anticonvulsant properties , 1985, Neuropharmacology.

[24]  D. Mclellan.  The electromyographic silent period produced by supramaximal electrical stimulation in normal man , 1973, Journal of neurology, neurosurgery, and psychiatry.